Asare Christian
Physical Medicine & Rehabilitation · Wayne, PANPI 1780818633
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $23,095 of the $34,638 with a category attached, or 66.7%. Ipsen Biopharmaceuticals, Inc accounts for 92.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $11,520 and has fallen 99.4% since, to $72 in 2025. Among physical medicine & rehabilitation clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 61 payments — averaging $567.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$32K
- Ipsen Pharma SAS$2K
- Teva Pharmaceuticals USA, Inc.$166
- Biohaven Pharmaceuticals, Inc.$144
- Amgen$134
- AbbVie$101
- plus $315 from 6 others
Across 23 payments — averaging $1786.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ipsen Pharma SAS$21K
- Ipsen Biopharmaceuticals, Inc$20K
What the payments were for
- Consulting fees$4,41013%
- Speaking & faculty fees$23,09567%
- Travel & lodging$4,43413%
- Food & beverage$2,6998%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 34 | $32,063 |
| Ipsen Pharma SAS | 5 | $1,715 |
| Teva Pharmaceuticals USA, Inc. | 4 | $166 |
| Biohaven Pharmaceuticals, Inc. | 2 | $144 |
| Amgen | 3 | $134 |
| AbbVie(2 entities) | 5 | $101 |
| Sumitomo Pharma America, Inc. | 1 | $98 |
| Dynasplint Systems Inc. | 1 | $64 |
| Merz North America, Inc. | 2 | $57 |
| Merz Pharmaceuticals, LLC | 2 | $45 |
| Boston Scientific | 1 | $27 |
| Insightec,inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DYSPORT$33,496
- AJOVY$125
- NURTEC ODT$125
- AIMOVIG$100
How this compares
$34,638 in reported general payments places this provider in the 95th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.
See all physical medicine & rehabilitation providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nucynta ErTapentadol Hcl | 12 | $15,537 |
| NucyntaTapentadol Hcl | 11 | $12,375 |
| Celecoxib | 37 | $355 |
| Gabapentin | 26 | $176 |
| Pregabalin | 12 | $175 |
| Amitriptyline Hcl | 26 | $157 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $146 |
| RizatriptanRizatriptan Benzoate | 15 | $134 |
| Tramadol Hcl | 27 | $92 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Wayne
- Andrew IsleibWayne$4K
- Jeffery RoweKing Of Prussia$1.9M
- Michael SaulinoElkins Park$425K
- Huaguang QuChalfont$356K
- Alberto EsquenaziPhiladelphia$305K
- Mitchell PaulinPaoli$229K
- Kimberly HeckertPhiladelphia$119K
- David LichtenReading$117K
- Gay WilcherRidley Park$81K
- Jessica MulhernPaoli$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.